Eduardo Candelario‐Jalil

This study shows that global Ripk2 deletion in aged mice reduces infarct size and improves motor function after ischemic stroke, suggesting RIPK2 as a therapeutic target.

This study shows that RIPK2 is essential for microglial inflammatory responses to MDP but not to LPS.

This study shows adropin protects against ischemic stroke by maintaining BBB integrity and reducing neuroinflammation, improving functional recovery in mice.